{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T10:28:45Z","timestamp":1768213725403,"version":"3.49.0"},"reference-count":35,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,12]]},"abstract":"\n Purpose of review<\/jats:title>\n We briefly address the advances in genetics, pathophysiology, and phenotypes of chronic granulomatous disease (CGD). This is one of the most studied primary immunodeficiencies, which comprise mutations in genes encoding the different subunits of the NADPH oxidase system. Those mutations lead to defective reactive oxygen species production, and consequently a failure to eliminate pathogens.<\/jats:p>\n <\/jats:sec>\n \n Recent findings<\/jats:title>\n Patients with CGD are susceptible to fungal, bacterial, and parasitic infections. Other symptoms, as systemic adverse effects to BCG vaccine and hyperinflammation, are also important clinical conditions in this disease. This wide-ranging clinical spectrum of CGD comes from heterogeneity of mutations, X-linked-CGD or autosomal recessive inheritance, and diverse environmental pressure factors. Early accurate diagnosis and prompt treatment are necessary to diminish the consequences of the disease. The most used diagnostic tests are dihydrorhodamine, cytochrome c<\/jats:italic> reduction, and luminol-enhanced chemiluminescence assay.<\/jats:p>\n <\/jats:sec>\n \n Summary<\/jats:title>\n The determination of mutations is essential for diagnosis confirmation and genetic counseling. CGD treatment usually includes prophylactic antibiotics and antifungals. Prophylactic recombinant human interferon-\u03b3, immunosuppressors or immune modulators may be, respectively, indicated for preventing infections or inflammatory manifestations. Hematopoietic stem cell transplantation and gene therapy are currently the available options for curative treatment of CGD.<\/jats:p>\n <\/jats:sec>","DOI":"10.1097\/mop.0000000000000830","type":"journal-article","created":{"date-parts":[[2019,9,15]],"date-time":"2019-09-15T17:41:59Z","timestamp":1568569319000},"page":"869-873","source":"Crossref","is-referenced-by-count":11,"title":["The extended understanding of chronic granulomatous disease"],"prefix":"10.1097","volume":"31","author":[{"given":"Raissa","family":"Lacerda-Pontes","sequence":"first","affiliation":[{"name":"Department of Immunology, Institute of Biomedical Sciences, University of S\u00e3o Paulo, S\u00e3o Paulo"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lillian Nunes","family":"Gomes","sequence":"additional","affiliation":[{"name":"Department of Immunology, Institute of Biomedical Sciences, University of S\u00e3o Paulo, S\u00e3o Paulo"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafael Sales de","family":"Albuquerque","sequence":"additional","affiliation":[{"name":"Department of Immunology, Institute of Biomedical Sciences, University of S\u00e3o Paulo, S\u00e3o Paulo"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paulo V\u00edtor","family":"Soeiro-Pereira","sequence":"additional","affiliation":[{"name":"Department of Pathology, Postgraduate Program in Health Sciences, Federal University of Maranh\u00e3o Medical School, S\u00e3o Lu\u00eds, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Condino-Neto","sequence":"additional","affiliation":[{"name":"Department of Immunology, Institute of Biomedical Sciences, University of S\u00e3o Paulo, S\u00e3o Paulo"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230918","first-page":"231","article-title":"Biochemical and genetic diagnosis of chronic granulomatous disease","author":"Roos","year":"2017","journal-title":"Chronic Granulomatous Disease - Genetics, Biology and Clinical Management"},{"key":"R2-20230918","doi-asserted-by":"crossref","first-page":"e26362","DOI":"10.1002\/pbc.26362","article-title":"Visceral leishmaniasis in two patients with IL-12p40 and IL-12R\u03b21 deficiencies","volume":"64","author":"Parvaneh","year":"2017","journal-title":"Pediatr Blood Cancer"},{"key":"R3-20230918","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1111\/pai.12814","article-title":"Inflammatory bowel disease in chronic granulomatous disease: an emerging problem over a twenty years\u2019 experience","volume":"28","author":"Angelino","year":"2017","journal-title":"Pediatr Allergy Immunol"},{"key":"R4-20230918","doi-asserted-by":"crossref","first-page":"e5234","DOI":"10.1371\/journal.pone.0005234","article-title":"Chronic granulomatous disease: the European experience","volume":"4","author":"van den Berg","year":"2009","journal-title":"PLoS One"},{"key":"R5-20230918","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1002\/pbc.25674","article-title":"Clinical and genotypic spectrum of chronic granulomatous disease in 71 Latin American Patients: first report from the LASID Registry","volume":"62","author":"de Oliveira-Junior","year":"2015","journal-title":"Pediatr Blood Cancer"},{"key":"R7-20230918","doi-asserted-by":"crossref","first-page":"3309","DOI":"10.1182\/blood-2009-07-231498","article-title":"A new genetic subgroup of chronic granulomatous disease with autosomal recessive mutations in p40 phox and selective defects in neutrophil NADPH oxidase activity","volume":"114","author":"Matute","year":"2009","journal-title":"Blood"},{"key":"R8-20230918","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1007\/s12325-017-0636-2","article-title":"A review of chronic granulomatous disease","volume":"34","author":"Arnold","year":"2017","journal-title":"Adv Ther"},{"key":"R9-20230918","doi-asserted-by":"crossref","first-page":"3957","DOI":"10.1172\/JCI97116","article-title":"Inherited p40 phox deficiency differs from classic chronic granulomatous disease","volume":"128","author":"Van De Geer","year":"2018","journal-title":"J Clin Invest"},{"key":"R10-20230918","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1007\/s10875-018-0486-y","article-title":"A cohort of 169 chronic granulomatous disease patients exposed to BCG vaccination: a retrospective study from a single center in Shanghai, China (2004\u20132017)","volume":"38","author":"Zhou","year":"2018","journal-title":"J Clin Immunol"},{"key":"R11-20230918","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3389\/fimmu.2019.00073","article-title":"Genetic and clinical profiles of disseminated Bacillus Calmette-Gu\u00e9rin disease and chronic granulomatous disease in China","volume":"10","author":"LI","year":"2019","journal-title":"Front Immunol"},{"key":"R12-20230918","doi-asserted-by":"crossref","first-page":"328","DOI":"10.3389\/fmicb.2016.00328","article-title":"Innate immunity holding the flanks until reinforced by adaptive immunity against Mycobacterium tuberculosis infection","volume":"7","author":"Khan","year":"2016","journal-title":"Front Microb"},{"key":"R13-20230918","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1189\/jlb.1205734","article-title":"Suppression of experimental colitis by intestinal mononuclear phagocytes","volume":"80","author":"Qualls","year":"2006","journal-title":"J Leukoc Biol"},{"key":"R14-20230918","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.ijantimicag.2017.08.029","article-title":"Reactive oxygen species: a novel antimicrobial","volume":"51","author":"Dryden","year":"2018","journal-title":"Int J Antimicrob Agents"},{"key":"R15-20230918","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.cub.2012.07.029","article-title":"Evolution of inflammatory diseases","volume":"22","author":"Okin","year":"2012","journal-title":"Curr Biol"},{"key":"R16-20230918","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1097\/BOR.0000000000000093","article-title":"Hyperinflammation, rather than hemophagocytosis, is the common link between macrophage activation syndrome and hemophagocytic lymphohistiocytosis","volume":"26","author":"Weaver","year":"2014","journal-title":"Curr Opin Rheumatol"},{"key":"R17-20230918","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/imr.12447","article-title":"Priming of the neutrophil respiratory burst: role in host defense and inflammation","volume":"273","author":"El-Benna","year":"2016","journal-title":"Immunol Rev"},{"key":"R18-20230918","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.bcp.2010.12.006","article-title":"Effect of apocynin, a NADPH oxidase inhibitor, on acute lung inflammation","volume":"81","author":"Impellizzeri","year":"2011","journal-title":"Biochem Pharmacol"},{"key":"R19-20230918","doi-asserted-by":"crossref","first-page":"e9631","DOI":"10.1371\/journal.pone.0009631","article-title":"NADPH oxidase limits innate immune responses in the lungs in mice","volume":"5","author":"Segal","year":"2010","journal-title":"PLoS One"},{"key":"R20-20230918","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2012\/252460","article-title":"Current concepts of hyperinflammation in chronic granulomatous disease","volume":"2012","author":"Rieber","year":"2012","journal-title":"Clin Dev Immunol"},{"key":"R21-20230918","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.jaci.2014.04.014","article-title":"Inflammatory manifestations in a single-center cohort of patients with chronic granulomatous disease","volume":"134","author":"Magnani","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"R22-20230918","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/cei.12202","article-title":"Molecular diagnosis of chronic granulomatous disease","volume":"175","author":"Roos","year":"2014","journal-title":"Clin Exp Immunol"},{"key":"R23-20230918","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1080\/15321810500403722","article-title":"A quantitative nitroblue tetrazolium assay for determining intracellular superoxide anion production in phagocytic cells","volume":"27","author":"Choi","year":"2006","journal-title":"J Immunoassay Immunochem"},{"key":"R24-20230918","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/00005792-200005000-00003","article-title":"Chronic granulomatous disease. Report on a national registry of 368 patients","volume":"79","author":"Winkelstein","year":"2000","journal-title":"Medicine (Baltimore)"},{"key":"R25-20230918","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/j.1365-2141.2007.06880.x","article-title":"Modern management of chronic granulomatous disease","volume":"140","author":"Seger","year":"2008","journal-title":"Br J Haematol"},{"key":"R26-20230918","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1086\/422993","article-title":"Long-term interferon-gamma therapy for patients with chronic granulomatous disease","volume":"39","author":"Marciano","year":"2004","journal-title":"Clin Infect Dis"},{"key":"R27-20230918","doi-asserted-by":"crossref","first-page":"3548","DOI":"10.1182\/blood.V95.11.3548","article-title":"Interferon-gamma improves splicing efficiency of CYBB gene transcripts in an interferonresponsive variant of chronic granulomatous disease due to a splice site consensus region mutation","volume":"95","author":"Condino-Neto","year":"2000","journal-title":"Blood"},{"key":"R28-20230918","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1542\/peds.48.5.730","article-title":"Chronic granulomatous disease: correlation between pathogenesis and clinical findings","volume":"48","author":"Johnston","year":"1971","journal-title":"Pediatrics"},{"key":"R29-20230918","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s11894-003-0040-8","article-title":"Optimizing antitumor necrosis factor strategies in inflammatory bowel disease","volume":"5","author":"Sandborn","year":"2003","journal-title":"Curr Gastroenterol Rep"},{"key":"R30-20230918","doi-asserted-by":"crossref","first-page":"3526","DOI":"10.1073\/pnas.1322831111","article-title":"IL-1 receptor blockade restores autophagy and reduces inflammation in chronic granulomatous disease in mice and in humans","volume":"111","author":"de Luca","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"key":"R31-20230918","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1086\/657308","article-title":"Complications of tumor necrosis factor-alpha blockade in chronic granulomatous disease-related colitis","volume":"51","author":"Uzel","year":"2010","journal-title":"Clin Infect Dis"},{"key":"R32-20230918","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1016\/j.jaci.2013.05.031","article-title":"Clinical outcome in children with chronic granulomatous disease managed conservatively or with hematopoietic stem cell transplantation","volume":"132","author":"Cole","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"R33-20230918","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1053\/j.seminhematol.2016.08.001","article-title":"Selecting the best haploidentical donor","volume":"53","author":"McCurdy","year":"2016","journal-title":"Semin Hematol"},{"key":"R34-20230918","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1007\/s10875-017-0422-6","article-title":"Allogeneic reduced-intensity hematopoietic stem cell transplantation for chronic granulomatous disease: a single-center prospective trial","volume":"37","author":"Parta","year":"2017","journal-title":"J Clin Immunol"},{"key":"R35-20230918","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1038\/mt.2010.226","article-title":"Biochemical correction of X-CGD by a novel chimeric promoter regulating high levels of transgene expression in myeloid cells","volume":"19","author":"Santilli","year":"2011","journal-title":"Mol Ther"},{"key":"R36-20230918","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1093\/jpids\/piy011","article-title":"Future of care for patients with chronic granulomatous disease: gene therapy and targeted molecular medicine","volume":"7","author":"Keller","year":"2018","journal-title":"J Pediatric Infect Dis Soc"}],"container-title":["Current Opinion in Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MOP.0000000000000830","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,18]],"date-time":"2023-09-18T02:24:38Z","timestamp":1695003878000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MOP.0000000000000830"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":35,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/mop.0000000000000830","relation":{},"ISSN":["1040-8703","1531-698X"],"issn-type":[{"value":"1040-8703","type":"print"},{"value":"1531-698X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12]]}}}